Unknown

Dataset Information

0

No association between three polymorphisms (rs1800629, rs361525 and rs1799724) in the tumor necrosis factor-? gene and susceptibility to prostate cancer: a comprehensive meta-analysis.


ABSTRACT: Inflammation is one of the factors associated with prostate cancer. The cytokine tumor necrosis factor-alpha (TNF-?) plays an important role in inflammation. Several studies have focused on the association between TNF-? polymorphisms and prostate cancer development. Our meta-analysis aimed to estimate the association between TNF-? rs1800629 (-?308?G/A), rs361525 (-?238?G/A) and rs1799724 polymorphisms and prostate cancer risk. Eligible studies were identified from electronic databases (PubMed, Embase, Wanfang and CNKI) using keywords: TNF-?, polymorphism, prostate cancer, until Nov 15, 2019. Odds ratios (ORs) with 95% confidence intervals (CIs) were applied to determine the association from a quantitative point-of-view. Publication bias and sensitivity analysis were also applied to evaluate the power of current study. All statistical analyses were done with Stata 11.0 software. Twenty-two different articles were included (22 studies about rs1800629; 8 studies for rs361525 and 5 studies related to rs1799724). Overall, no significant association was found between rs1800629 and rs1799724 polymorphisms and the risk of prostate cancer in the whole (such as: OR?=?1.03, 95% CI?=?0.92-1.16, P =?0.580 in the allele for rs1800629; OR?=?0.95, 95% CI?=?0.84-1.07, P =?0.381 in the allele for rs1799724). The rs361525 polymorphism also had no association with prostate cancer in the cases (OR?=?0.93, 95% CI?=?0.66-1.32, P =?0.684 in the allele) and ethnicity subgroup. The stratified subgroup of genotype method, however, revealed that the rs361525 variant significantly decreased the risk of prostate cancer in the Others (OR?=?0.65, 95% CI?=?0.47-0.89, P?=?0.008, A-allele vs G-allele) and PCR-RFLP (OR?=?2.68, 95% CI?=?1.00-7.20, P?=?0.050, AG vs GG or AA+AG vs GG) methods. In summary, the findings of the current meta-analysis indicate that the TNF-? rs1800629, rs361525 and rs1799724 polymorphisms are not correlated with prostate cancer development, although there were some pooled positive results. Further well-designed studies are necessary to form more precise conclusions.

SUBMITTER: Yin L 

PROVIDER: S-EPMC7137332 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

No association between three polymorphisms (rs1800629, rs361525 and rs1799724) in the tumor necrosis factor-α gene and susceptibility to prostate cancer: a comprehensive meta-analysis.

Yin Lei L   Yue Chuang C   Jing Hongwei H   Yu Hongyuan H   Zuo Li L   Liu Tao T  

Hereditas 20200407 1


<h4>Background</h4>Inflammation is one of the factors associated with prostate cancer. The cytokine tumor necrosis factor-alpha (TNF-α) plays an important role in inflammation. Several studies have focused on the association between TNF-α polymorphisms and prostate cancer development. Our meta-analysis aimed to estimate the association between TNF-α rs1800629 (- 308 G/A), rs361525 (- 238 G/A) and rs1799724 polymorphisms and prostate cancer risk.<h4>Methods</h4>Eligible studies were identified fr  ...[more]

Similar Datasets

| S-EPMC5762335 | biostudies-literature
| S-EPMC9319996 | biostudies-literature
| S-EPMC4503166 | biostudies-literature
| S-EPMC10655976 | biostudies-literature
| S-EPMC4707537 | biostudies-literature
| S-EPMC4402788 | biostudies-literature
| S-EPMC3755002 | biostudies-literature
| S-EPMC4061054 | biostudies-literature
| S-EPMC10140545 | biostudies-literature
| S-EPMC9145848 | biostudies-literature